Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kates

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Connecticut Medicine|September 25, 2003
Is it necessary to obtain serum levels of thyroid stimulating hormone and prolactin in asymptomatic women with infertility?August C Olivar, Linda M Chaffkin, Richard J Kates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastasesTimothy Akhurst, Tara J Kates, Madhu Mazumdar, et al.
Journal of Medicinal Chemistry|February 17, 1995
Studies on new acidic azoles as glucose-lowering agents in obese, diabetic db/db miceK L Kees, T J Caggiano, K E Steiner, et al.
The Journal of Spinal Cord Medicine|October 23, 2018
Midsagittal tissue bridges are associated with walking ability in incomplete spinal cord injury: A magnetic resonance imaging case seriesDenise R O'Dell, Kenneth A Weber, Jeffrey C Berliner, et al.
Spinal Cord Series and Cases|June 27, 2019
Establishing the inter-rater reliability of spinal cord damage manual measurement using magnetic resonance imagingDavid P Cummins, Jordan R Connor, Katherine A Heller, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Discovery of VU2957 (Valiglurax): An mGlu<sub>4</sub> Positive Allosteric Modulator Evaluated as a Preclinical Candidate for the Treatment of Parkinson's DiseaseJoseph D Panarese, Darren W Engers, Yong-Jin Wu, et al.
ACS Chemical Neuroscience|December 11, 2024
Discovery of VU0467319: an M<sub>1</sub> Positive Allosteric Modulator Candidate That Advanced into Clinical TrialsMichael S Poslunsey, Michael R Wood, Changho Han, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Connecticut Medicine|September 25, 2003
Is it necessary to obtain serum levels of thyroid stimulating hormone and prolactin in asymptomatic women with infertility?August C Olivar, Linda M Chaffkin, Richard J Kates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastasesTimothy Akhurst, Tara J Kates, Madhu Mazumdar, et al.
Journal of Medicinal Chemistry|February 17, 1995
Studies on new acidic azoles as glucose-lowering agents in obese, diabetic db/db miceK L Kees, T J Caggiano, K E Steiner, et al.
The Journal of Spinal Cord Medicine|October 23, 2018
Midsagittal tissue bridges are associated with walking ability in incomplete spinal cord injury: A magnetic resonance imaging case seriesDenise R O'Dell, Kenneth A Weber, Jeffrey C Berliner, et al.
Spinal Cord Series and Cases|June 27, 2019
Establishing the inter-rater reliability of spinal cord damage manual measurement using magnetic resonance imagingDavid P Cummins, Jordan R Connor, Katherine A Heller, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Discovery of VU2957 (Valiglurax): An mGlu<sub>4</sub> Positive Allosteric Modulator Evaluated as a Preclinical Candidate for the Treatment of Parkinson's DiseaseJoseph D Panarese, Darren W Engers, Yong-Jin Wu, et al.
ACS Chemical Neuroscience|December 11, 2024
Discovery of VU0467319: an M<sub>1</sub> Positive Allosteric Modulator Candidate That Advanced into Clinical TrialsMichael S Poslunsey, Michael R Wood, Changho Han, et al.
Pageof 4